CP Reports Store
Current Partnering is the market-leading publisher of pharmaceutical and biotechnology dealmaking intelligence reports covering licensing agreements, collaboration agreements, co-development deals, M&A transactions, strategic alliances and partnering activity across the life sciences industry.
Our reports provide detailed analysis of real-world deal structures and financial terms, including upfront payments, milestone payments, royalty rates, equity investments and option-based deal mechanisms. Drawing on thousands of disclosed agreements, the reports enable business development and licensing professionals to benchmark comparable transactions and understand how partnerships are structured across therapeutic areas, technologies and company types.
Beyond financial terms, Current Partnering tracks key contractual provisions including exclusivity arrangements, geographic and territorial rights, regional licensing structures, development and commercialization responsibilities, co-promotion rights, manufacturing rights, intellectual property provisions and rights allocation between partners. This enables users to evaluate not only deal value but also how strategic control, risk and commercial opportunity are distributed between parties.
Coverage spans a broad range of therapeutic areas and technologies, including oncology, immunology, rare diseases, cell therapy, gene therapy, antibody-drug conjugates (ADCs), RNA therapeutics, vaccines and precision medicine.
Reports are widely relied upon globally by business development, licensing, corporate strategy, competitive intelligence and executive leadership teams to identify partners, benchmark transactions and support dealmaking decisions with real-world market evidence.
Browse our deal reports by: Deal Structure | Therapy | Technology | Development Stage | Industry | Annual Subscriptions
-
Cell Therapy Collaboration and Licensing Deals 2016-2026May 2026$4,995.00Cell Therapy Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Artificial Intelligence (AI) Collaboration and Licensing Deals in Pharma, Biotech and Diagnostics 2019-2026May 2026$4,995.00Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2026
Learn More -
Vaccine Collaboration and Licensing Deals 2016-2026May 2026$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2026
Learn More -
Companion Diagnostic Collaboration and Licensing Deals 2010-2026May 2026$3,995.00Companion Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2026
Learn More -
Drug Delivery Collaboration and Licensing Deals 2019-2026May 2026$4,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2026
Learn More -
Antibody Collaboration and Licensing Deals 2019-2026May 2026$4,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2026
Learn More -
Oncology Collaboration and Licensing Deals 2021-2026April 2026$4,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2021 to 2026
Learn More -
Psychiatry Collaboration and Licensing Deals 2019-2026April 2026$3,995.00Psychiatry Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2026
Learn More -
Infectious Disease Collaboration and Licensing Deals 2020-2026April 2026$4,995.00Infectious Disease Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2026
Learn More
